课题基金 / 基金详情

NEW TREATMENT FOR MYOCARDIAL INFARCTION BY XENO-FETAL CARDIOMYOCYTE TRANSPLANTATION

NEW TREATMENT FOR MYOCARDIAL INFARCTION BY XENO-FETAL CARDIOMYOCYTE TRANSPLANTATION
异种胎儿心肌细胞移植治疗心肌梗死的新方法
批准号:
11671326
负责人:
HAMANO Kimikazu
金额:
$2.43万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

HAMANO Kimikazu的其他基金

相关文献

中文摘要
翻译
背景资料。胚胎心肌细胞同种异体移植已成功进行。在本研究中,我们试图通过CTLA4-Ig基因转移阻断CD28/B7共刺激通路,将大鼠胚胎心肌细胞移植到小鼠心脏。以表达CTLA4-Ig的腺病毒载体(AdCTLA)感染DA大鼠胎鼠心肌细胞,将其直接注射入C3H/He小鼠正常心肌(n=15)。将感染β-Gal的腺病毒载体(AdRL)的细胞和未感染的细胞注射到另外30只小鼠体内作为对照。用X-Gal染色或抗CTLA4-Ig抗体免疫染色检测AdRL或AdCTLA感染心肌细胞的百分率。分别于异种移植后2周、4周、8周处死小鼠。用抗大鼠心房利钠肽(ANP)和抗CTLA4-Ig抗体进行免疫组织化学染色,观察移植心肌细胞的存活情况。X-Gal染色和免疫染色显示,在感染AdCTLA或AdRL后3d,10moi、50moi和100moi的感染率分别约为30%、65%和50~70%。AdCTLA感染的小鼠心肌细胞均表达CTLA4-Ig,移植后存活至8周。但在异种移植后2周仍未检测到感染AdRL的心肌细胞和未感染的心肌细胞。AdCTLA和AdRL成功地感染了胎儿心肌细胞,腺病毒介导的CTLA4-Ig表达延长了异种移植胎儿心肌细胞的存活时间。
英文摘要
Background. Experimental allografting of fetal cardiomyocytes has been performed successfully. In this study, we attempted to transplant rat fetal cardiomyocytes into the hearts of mice by blocking the CD28/B7 co-stimulatory pathway via CTLA4-Ig gene transfer.Methods. Fetal cardiomyocytes derived from Dark Agouti (DA) rat were infected with CTLA4-Ig-expressing adenovirus vectors (AdCTLA) and injected directly into the normal myocardium of C3H/He mice (n=15). For control, cells infected with β-Gal-expressing adenovirus vector (AdRL) and cells without infection were injected into additional mice (n=30). The percentages of cardiomyocytes infection by AdRL or AdCTLA were estimated by X-gal staining or immunostaining with anti-CTLA4-Ig antibody. Mice were killed at 2 (n=5), 4 (n=5), and 8 (n=5) weeks after xenotransplantation. Transplanted fetal cardiomyocytes were examined for survival by immunostaining with anti-rat artial natriuretic peptide (ANP) and anti-CTLA4-Ig antibodies.Results. X-gal staining and immunostaining showed infection to be approximately 30% at 10 MOI, 65% at MOI 50, and 50〜70% at MOI>100, 3 days after infection with AdCTLA or AdRL.The cardiomyocytes infected with AdCTLA expressed CTLA4-Ig and survived to 8 weeks after xenotransplantation in all of these mice. However, cardiomyocytes infected with AdRL and non-infected cells were not detected even 2 weeks after xenotransplantation.Conclusion. Fetal cardiomyocytes were successfully infected by AdCTLA and AdRL.Survival of xenografted fetal cardiomyocytes is prolonged by adenovirus-mediated CTLA4-Ig expression.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Niimi M: "Oral delivery of xeno-antigen combined with non-depleting anti-CD4 monoclonal antibody induces significantly prolonged survival of concordant skin xenograft."Xenotransplantation. 8. 75-79 (2001)
Niimi M:“口服异种抗原与非消耗性抗 CD4 单克隆抗体相结合,可显着延长一致皮肤异种移植物的存活时间。”异种移植。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Niimi M, et al.: "Oral delivery of xeno-antigen combined with non-depleting anti-CD4 monoclonal antibody induces significantly prolonged survival of concordant skinxenograft."Xenotransplantation. 8. 75-79 (2001)
Niimi M 等人:“口服异种抗原与非消耗性抗 CD4 单克隆抗体相结合,可显着延长一致皮肤异种移植物的存活时间。” 异种移植。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hamano K: "Graft vasculopathy and tolerance : does the balance of Th cells contribute to graft vasculopathy?"J Surg Res. 93. 28-34 (2000)
Hamano K:“移植血管病变和耐受性:Th 细胞的平衡是否会导致移植血管病变?”J Surg Res。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hamano K, et al.: "Graft vasculopathy and tolerance : does the balance of Th cells contribute to graft vasculopathy?"Journal of Surgical Research. 93. 28-34 (2000)
Hamano K 等人:“移植血管病变和耐受性:Th 细胞的平衡是否会导致移植血管病变?”《外科研究杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Development of exosomes accumulating in ischemic tissues for angiogenesis
  • 批准号:
    19K22660
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
  • 资助金额:
    $4.16万
  • 财政年份:
    2019
  • 负责人:
    HAMANO Kimikazu
  • 依托单位:
Development of vascular regeneration therapy by exosome derived from enhanced cells
  • 批准号:
    19H03739
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.07万
  • 财政年份:
    2019
  • 负责人:
    HAMANO Kimikazu
  • 依托单位:
Challenges to rejuvenate aged-cardiac stem cells by genome editing to develop next generation therapeutic strategies for heart failure.
  • 批准号:
    15K15508
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.33万
  • 财政年份:
    2015
  • 负责人:
    HAMANO Kimikazu
  • 依托单位:
Development of transplantation therapy using hypoxically preconditioned cell sheets for lower limb ischemic ulcers
  • 批准号:
    15H04939
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $10.57万
  • 财政年份:
    2015
  • 负责人:
    HAMANO Kimikazu
  • 依托单位: